Oncotelic Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Oncotelic Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $250K, a 25% increase year-over-year.
  • Oncotelic Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.25M, a 11.1% increase from 2022.
  • Oncotelic Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.13M, a 75.2% decline from 2021.
  • Oncotelic Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $4.53M, a 40.5% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.25M +$125K +11.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-12
2022 $1.13M -$3.4M -75.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-12
2021 $4.53M +$1.31M +40.5% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-20
2020 $3.22M +$1.05M +48.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 $2.17M +$1.93M +805% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-15
2018 $240K Jan 1, 2018 Dec 31, 2018 10-K 2020-05-14
2013 $9.1M +$5.78M +174% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-20
2012 $3.32M -$13.8M -80.7% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-20
2011 $17.2M +$6.06M +54.6% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-20
2010 $11.1M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.